USFDA concludes inspection at unit-IV of Aurobindo Pharma’s arm

18 Dec 2025 Evaluate

The United States Food and Drug Administration (US FDA) has concluded inspection at Unit-IV of APL Healthcare, a wholly owned subsidiary of Aurobindo Pharma situated at Palchur village. 

At the end of the current inspection, a ‘Form 483’ was issued with 05 observations which are procedural in nature, and the company will respond to the US FDA within the stipulated timelines. The Company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1209.90 16.85 (1.41%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.35
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 913.85
Lupin 2118.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×